Spectrum Pharmaceuticals
Financial ratios & Valuation

Historical Multiples (2013 – 2022)

2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 TTM Median
Valuation Ratios
Price/Earnings ratio
-8.64-9.80-7.70-4.70-17.67-7.53-2.97-2.47-1.24-0.86-1.19-17.67
Price/Sales ratio
3.442.402.402.2012.568.2617.79N/AN/A6.673.26K12.56
Price/Book Value ratio
1.901.761.831.364.593.192.113.154.132.423.543.54
Price/Cash Flow ratio
-257.64-123.6358.01-7.97-41.51-14.48-2.98-3.48-1.64-0.69-1.24-41.51
Price/Free Cash Flow ratio
-102.43-98.3159.99-7.95-41.02-13.87-2.80-3.33-1.64-0.69-1.24-41.02
Price/Earnings Growth ratio
0.050.32-0.78-0.22-1.27-0.89-0.57-0.180.040.01-0.07-1.27
Dividend Yield
N/AN/AN/A0.00%N/AN/AN/AN/AN/AN/AN/AN/A
Profitability Indicator Ratios
Gross Profit Margin
81.66%85.52%82.96%75.52%63.21%75.52%46.90%N/AN/A82.28%-7.69%75.52%
Operating Profit Margin
-24.88%-16.89%-25.05%-42.08%-75.29%-119.97%-636.89%N/AN/A-718.77%-251041.02%-119.97%
Pretax Profit Margin
-23.50%-23.30%-30.99%-48.36%-84.15%-109.76%-639.37%N/AN/A-771.78%-272015.38%-109.76%
Net Profit Margin
-39.86%-24.47%-31.24%-46.78%-71.08%-109.76%-598.65%N/AN/A-772.23%-272128.20%-109.76%
Effective Tax Rate
-69.59%-5.02%-0.80%3.26%15.53%-0.00%6.36%0.03%-0.00%-0.05%-0.03%-0.00%
Return on Assets
-12.44%-9.32%-12.05%-15.97%-18.71%-30.70%-51.39%-87.02%-142.03%-75.58%-89.23%-30.70%
Return On Equity
-22.06%-17.96%-23.85%-29.02%-25.97%-42.36%-71.10%-127.58%-333.17%-280.06%-246.66%-42.36%
Return on Capital Employed
-9.47%-8.29%-11.81%-16.96%-25.59%-43.09%-71.49%-118.15%-253.26%-119.85%-141.26%-43.09%
Liquidity Ratios
Current Ratio
2.612.032.503.302.532.893.933.51N/AN/A2.272.89
Quick Ratio
2.401.942.453.172.472.853.933.511.952.152.032.85
Cash ratio
1.731.181.832.412.071.821.030.861.660.941.131.82
Days of Sales Outstanding
133.54148.9596.45113.4997.79112.07161.38N/AN/A491.275.48K97.79
Days of Inventory outstanding
172.65124.2055.0488.7444.1748.42N/AN/AN/A1.87K81.45K44.17
Operating Cycle
306.19273.15151.50202.24141.97160.50161.38N/AN/A2.37K82.80K141.97
Days of Payables Outstanding
163.411.14K745.30534.45449.25947.551.65KN/AN/A7.76K304.21K449.25
Cash Conversion Cycle
142.77-874.26-593.80-332.20-307.27-787.05-1.48KN/AN/A-5.39K-278.64K-787.05
Debt Ratios
Debt Ratio
0.180.210.260.240.070.020.010.000.010.280.690.07
Debt Equity Ratio
0.320.410.510.440.100.030.020.010.021.052.310.10
Long-term Debt to Capitalization
0.240.270.320.29N/AN/A0.01N/AN/A0.500.44N/A
Total Debt to Capitalization
0.240.290.340.300.090.030.020.010.020.510.440.09
Interest Coverage Ratio
-17.69-3.67-4.48-6.53-14.21-385.8128.16N/AN/AN/A-328.54-385.81
Cash Flow to Debt Ratio
-0.02-0.030.06-0.38-1.01-6.33-33.20-78.77-93.20-3.29-3.48-3.48
Company Equity Multiplier
1.771.921.971.811.381.371.381.462.343.703.311.38
Cash Flow Ratios
Operating Cash Flow / Sales Ratio
-0.01-0.010.04-0.27-0.30-0.57-5.95N/AN/A-9.58-2.61K-0.57
Free Cash Flow / Operating Cash Flow Ratio
2.511.250.961.001.011.041.061.041.001.001.001.04
Cash Flow Coverage Ratio
-0.02-0.030.06-0.38-1.01-6.33-33.20-78.77-93.20-3.29-3.48-3.48
Short Term Coverage Ratio
N/A-0.420.82-4.50-1.01-6.33-79.99-78.77-93.20-127.44-135.63-6.33
Dividend Payout Ratio
N/AN/AN/A-0.00%N/AN/AN/AN/AN/AN/AN/AN/A